Clinical trials in Rotterdam – page 58

809 clinical trials in Rotterdam, The Netherlands across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Rotterdam at a glance

809

clinical trials

Research sites7

Quick filters

809 trials in Rotterdam

Open in trial search

Endometrial cancer+5

Not recruiting

A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

InvestigationalNo placebo

A Phase 1/2a Study of BNT142 Safety and Early Effectiveness in Patients with Advanced Solid Tumors Expressing CLDN6 Protein

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Sponsor:BioNTech SE

Contact Research Centre

Hypereosinophilic syndrome

Not recruiting

Study on Mepolizumab for Children and Teens with Hypereosinophilic Syndrome

Registered drugNo placebo

Study on Mepolizumab for Children and Teens with Hypereosinophilic Syndrome

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Mepolizumab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

IgA nephropathy

Not recruiting

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Registered drug

Study on Ravulizumab for Adults with Immunoglobulin A Nephropathy (IgAN) to Preserve Kidney Function

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ravulizumab
Sponsor:Alexion Pharmaceuticals Inc.

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Registered drugNo placebo

Study of ibrutinib and venetoclax combination therapy for patients with relapsed or refractory chronic lymphocytic leukemia who have adequate kidney function

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Ibrutinib
Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Contact Research Centre

Neoplasm

Not recruiting

Study on the Safety and Effects of [177Lu]-NeoB in Patients with Advanced Solid Tumors Overexpressing GRPR

InvestigationalNo placebo

Study on the Safety and Effects of [177Lu]-NeoB in Patients with Advanced Solid Tumors Overexpressing GRPR

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Lutetium (177LU)-NEOBOMB1
Sponsor:Advanced Accelerator Applications International S.A.

Contact Research Centre

Respiratory syncytial virus infection

Not recruiting

Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

Investigational

Study on the Effectiveness and Safety of EDP-938 for Adults with High-Risk Respiratory Syncytial Virus (RSV) Infection

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Zelicapavir
Sponsor:Enanta Pharmaceuticals Inc.

Contact Research Centre

Glycogen storage disease type II

Not recruiting

Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease

Registered drugNo placebo

Study on the Effectiveness and Safety of Avalglucosidase Alfa for Babies with Infantile-Onset Pompe Disease

Registered drugNo placebo

The Netherlands

Participants:0–17 years
Substances:Avalglucosidase Alfa
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

Registered drug

Study on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes

Registered drug

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Colecalciferol
Sponsor:Diamyd Medical AB

Contact Research Centre

Thrombotic thrombocytopenic purpura

Not recruiting

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

Study on Caplacizumab and Immunosuppressive Therapy for Adults with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Caplacizumab
Sponsor:Sanofi-Aventis Recherche & Developpement

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Study of Datopotamab Deruxtecan for Patients with Advanced or Metastatic Non-small Cell Lung Cancer with Specific Genetic Changes

InvestigationalNo placebo

Study of Datopotamab Deruxtecan for Patients with Advanced or Metastatic Non-small Cell Lung Cancer with Specific Genetic Changes

InvestigationalNo placebo

The Netherlands

Participants:18–64 years
Substances:Datopotamab Deruxtecan
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Primary immunodeficiency syndrome+2

Not recruiting

Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

Registered drugNo placebo

Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

Registered drugNo placebo

The Netherlands

Participants:0–17 years · 18–64 years
Substances:Human Normal Immunoglobulin
Sponsor:Universitair Medisch Centrum Utrecht

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Rotterdam

What the registry says about research in the country

01 Neurology and Mental Health

Innovative research focusing on frontotemporal dementia treatments and management of migraine in relation to obesity. Studies include evaluation of new therapeutic compounds and their effects on neurological conditions.

Dementia Treatment Studies
Migraine Management Research
Neurological Disease Interventions

Research aims to improve patient outcomes through targeted therapeutic approaches and innovative treatment methods.

02 Oncology and Cancer Research

Comprehensive studies targeting various forms of cancer, including advanced gastric cancer and bladder cancer. Research includes innovative imaging techniques and combination therapy approaches.

Gastric Cancer Treatment
Cancer Immunotherapy
Diagnostic Imaging Studies

Focus on developing more effective treatment strategies and improving diagnostic capabilities.

03 Metabolic and Endocrine Disorders

Clinical trials addressing obesity and related metabolic conditions, including innovative approaches to weight management and metabolic disease treatment. Studies evaluate new therapeutic options for thyroid disorders.

Weight Management Therapies
Thyroid Disease Treatment
Metabolic Disease Research

Research focuses on developing effective treatments for complex metabolic conditions.

Back to the Netherlands All countries